JY
TGAN

Jeff Yass’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Jeff Yass’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,926
Closed -$43.5K – 13687
2023
Q4 		$43.5K Buy
+11,926
New +$32.7K ﹤0.01% 11765
2022
Q3 		– Sell
-66,146
Closed -$252K – 14362
2022
Q2 		$252K Buy
+66,146
New +$422K ﹤0.01% 10039

Other funds holding TGAN

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's TGAN Position: Q1 2024 in Review

Jeff Yass sold out of Transphorm, Inc. Common Stock (TGAN) in Q1 2024, closing a stake of 11,926 shares — an estimated $43.5K sold.

Jeff Yass first reported a position in TGAN in Q2 2022 and held it in 2 quarters. The position peaked at $252K in Q2 2022. 57 funds tracked by Wall St. Rank hold TGAN as of Q1 2024.

  • Jeff Yass reported no remaining Transphorm, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jeff Yass sold 11,926 Transphorm, Inc. Common Stock shares in Q1 2024, an estimated $43.5K.
  • Jeff Yass first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Jeff Yass's Transphorm, Inc. Common Stock position peaked at $252K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.